XML 42 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Plans and Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Option Activity under Stock-Based Compensation Plans

Activity under our stock plans is set forth below:

 

 

 

Shares
Underlying
Outstanding
Options
(in thousands)

 

 

Weighted-
Average
Exercise
Price Per Share

 

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value (in thousands)

 

Balance as of December 31, 2021

 

 

10,399

 

 

$

11.55

 

 

 

4.16

 

 

$

42,756

 

Options granted

 

 

2,053

 

 

 

12.54

 

 

 

 

 

 

 

Options exercised

 

 

(1,171

)

 

 

8.10

 

 

 

 

 

 

 

Options cancelled:

 

 

 

 

 

 

 

 

 

 

 

 

Options forfeited (unvested)

 

 

(105

)

 

 

9.40

 

 

 

 

 

 

 

Options expired (vested)

 

 

(1,828

)

 

 

19.11

 

 

 

 

 

 

 

Balance at September 30, 2022

 

 

9,348

 

 

$

10.75

 

 

 

4.85

 

 

$

15,323

 

Vested and expected to vest at September 30, 2022

 

 

9,081

 

 

$

10.70

 

 

 

4.81

 

 

$

15,241

 

Exercisable at September 30, 2022

 

 

5,056

 

 

$

10.10

 

 

 

3.95

 

 

$

12,300

 

Summary of Restricted Stock Units Activity

Restricted stock unit activity under our stock-based compensation plans during the nine months ended September 30, 2022 was as follows:

 

 

 

Number of Shares
(in thousands)

 

 

Weighted-Average
Grant-Date Fair
Value Per Share

 

Non-vested as of December 31, 2021

 

 

2,651

 

 

$

8.30

 

Granted

 

 

2,145

 

 

 

12.43

 

Vested

 

 

(1,195

)

 

 

7.72

 

Forfeited

 

 

(254

)

 

 

10.58

 

Non-vested as of September 30, 2022

 

 

3,347

 

 

$

10.98

 

Summary Of Performance Based Restricted Stock Unit

We granted performance-based restricted stock unit (“PSU”) to certain executives. These PSUs vest upon a specified market condition. The summary of PSU activities for the nine months ended September 30, 2022 is as follows:

 

 

 

Number of Shares
(in thousands)

 

 

Weighted-Average
Grant-Date Fair
Value Per Share

 

Non-vested as of December 31, 2021

 

 

237

 

 

$

8.40

 

Granted

 

 

193

 

 

 

11.62

 

Vested

 

 

(237

)

 

 

8.40

 

Non-vested as of September 30, 2022

 

 

193

 

 

$

11.62

 

Fair Value-Based Measurements and Weighted-Average Assumptions The weighted-average assumptions used in the calculations of these fair value measurements are as follows:

 

 

 

Stock Options

 

 

Stock Options

 

 

Market-Based Performance Stock Unit (“PSUs”)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

September 30

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

2022

 

Weighted-average fair value per share

 

$

-

 

 

$

7.91

 

 

$

7.97

 

 

$

6.85

 

 

$

11.62

 

Risk-free interest rate

 

 

-

 

 

 

0.7

%

 

 

2.01

%

 

 

0.6

%

 

 

1.7

%

Expected life (in years)

 

 

-

 

 

 

4.5

 

 

 

4.5

 

 

 

4.5

 

 

 

2.9

 

Volatility

 

 

-

 

 

 

0.9

 

 

 

0.8

 

 

 

1.0

 

 

 

0.9

 

Stock-Based Compensation Expense

The components of stock-based compensation expense were as follows (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development

 

$

1,532

 

 

$

798

 

 

$

4,271

 

 

$

2,607

 

Selling, general and administrative

 

 

6,019

 

 

 

3,930

 

 

 

17,043

 

 

 

10,519

 

Cost of sales - product

 

 

323

 

 

 

124

 

 

 

626

 

 

 

448

 

Inventory

 

 

739

 

 

 

524

 

 

 

2,248

 

 

 

1,549

 

Total

 

$

8,613

 

 

$

5,376

 

 

$

24,188

 

 

$

15,123